Oral administration of attenuated S. typhimurium carrying shRNA-expressing vectors as a cancer therapeutic
RNAi has been successfully applied in genomic research, and it also holds considerable promise as a therapeutic approach to suppress disease-causing gene expression. Here, we show that attenuated S. typhimurium were capable of delivering shRNA-expressing vectors to mammalian cells and inducing RNAi...
Saved in:
Published in | Cancer biology & therapy Vol. 7; no. 1; pp. 145 - 151 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Taylor & Francis
01.01.2008
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | RNAi has been successfully applied in genomic research, and it also holds considerable promise as a therapeutic approach to suppress disease-causing gene expression. Here, we show that attenuated S. typhimurium were capable of delivering shRNA-expressing vectors to mammalian cells and inducing RNAi in vitro and in vivo. Upon oral administration, S.typhimurium carrying shRNA-expressing vectors targeting bcl2 induced significant gene silencing in murine melanoma cells that led to a remarkably delayed tumor growth and prolonged survival in the mouse model. These results suggest that bacteria mediated RNAi may be a new potent approach to the treatment of cancers. |
---|---|
AbstractList | RNAi has been successfully applied in genomic research, and it also holds considerable promise as a therapeutic approach to suppress disease-causing gene expression. Here, we show that attenuated S. typhimurium were capable of delivering shRNA-expressing vectors to mammalian cells and inducing RNAi in vitro and in vivo. Upon oral administration, S.typhimurium carrying shRNA-expressing vectors targeting bcl2 induced significant gene silencing in murine melanoma cells that led to a remarkably delayed tumor growth and prolonged survival in the mouse model. These results suggest that bacteria mediated RNAi may be a new potent approach to the treatment of cancers. |
Author | Chen, Lishan Ren, Daming Li, Shenghua Yang, Nan Zhu, Xiangying |
Author_xml | – sequence: 1 givenname: Nan surname: Yang fullname: Yang, Nan – sequence: 2 givenname: Xiangying surname: Zhu fullname: Zhu, Xiangying – sequence: 3 givenname: Lishan surname: Chen fullname: Chen, Lishan – sequence: 4 givenname: Shenghua surname: Li fullname: Li, Shenghua – sequence: 5 givenname: Daming surname: Ren fullname: Ren, Daming |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/18059172$$D View this record in MEDLINE/PubMed |
BookMark | eNptkE1v1DAQhi1URD_gxhnlxIkE24nj5FhVtEWqqNTC2Zo4E9ZVEoexQ9l_j6Nd4IJkaazRM--MnnN2MvsZGXsreFGJWny0XSx0IQolWvWCnQmlVN4oXZ9s_7LJK17pU3YewhPnUsu6fcVORcNVK7Q8Y0_3BGMG_eRmFyJBdH7O_JBBjDivELHPHoss7pedm1Zy65RZINq7-XsWdg9fLnP8tRCGsDV-oo2eQgbpJWy2SFncIcGCa3T2NXs5wBjwzbFesG_Xn75e3eZ39zefry7vcltVTcyHpuVtqXQDSkEpm0ZYC6ouu6HtlKhqkFzzGq0GLluusOusBAlKl9I2VSvLC_b-kLuQ_7FiiGZyweI4wox-DaZuRSV1qRP44QBa8iEQDmYhNwHtjeBmc2uSW6ONMJvbhL875q7dhP0_-CgzAfwApE09hs75YB0mDX_RLQ8ouRjxT6Y-jLh58DTBs6exNxH2o6eBkkIXTPnfa34DDIWc8A |
CitedBy_id | crossref_primary_10_1016_j_addr_2016_09_007 crossref_primary_10_1016_j_intimp_2020_107052 crossref_primary_10_1007_s00109_010_0636_z crossref_primary_10_1016_j_bmhimx_2015_02_005 crossref_primary_10_3724_abbs_2023007 crossref_primary_10_1007_s13139_016_0415_z crossref_primary_10_1016_j_biopha_2021_112443 crossref_primary_10_1038_s41571_024_00908_9 crossref_primary_10_2478_s11658_009_0032_2 crossref_primary_10_1016_j_molmed_2012_05_006 crossref_primary_10_1097_CJI_0b013e3181cf23a6 crossref_primary_10_1073_pnas_1201620109 crossref_primary_10_1016_j_heliyon_2023_e17148 crossref_primary_10_1039_D1BM00634G crossref_primary_10_1073_pnas_0912813107 crossref_primary_10_3858_emm_2011_43_2_008 crossref_primary_10_1016_j_canlet_2019_01_037 crossref_primary_10_3389_fimmu_2023_1277677 crossref_primary_10_1080_1061186X_2020_1737087 crossref_primary_10_1111_1751_7915_13523 crossref_primary_10_3390_biomedicines9111566 crossref_primary_10_1049_enb2_12032 crossref_primary_10_1038_nrc2934 crossref_primary_10_1038_gt_2010_112 crossref_primary_10_1038_mt_2013_37 crossref_primary_10_3389_fcimb_2023_1293351 crossref_primary_10_1016_j_intimp_2024_111935 crossref_primary_10_1371_journal_pone_0129276 crossref_primary_10_4161_bbug_1_6_13146 crossref_primary_10_1155_2016_8451728 crossref_primary_10_1016_j_tibtech_2010_07_009 crossref_primary_10_1039_c1mb05016h crossref_primary_10_1002_jso_24644 crossref_primary_10_1016_j_addr_2022_114366 crossref_primary_10_1371_journal_pone_0065268 crossref_primary_10_3390_pharmaceutics14040784 crossref_primary_10_1089_dna_2010_1118 crossref_primary_10_61186_ijbc_15_4_178 crossref_primary_10_3390_cancers11091314 crossref_primary_10_1016_j_actbio_2021_02_006 crossref_primary_10_3390_cancers11101592 crossref_primary_10_1073_pnas_1014975108 crossref_primary_10_3390_pharmaceutics14102100 crossref_primary_10_1016_j_cyto_2016_01_002 crossref_primary_10_1016_j_copbio_2011_03_009 crossref_primary_10_1016_j_cbpa_2012_04_009 crossref_primary_10_3389_fimmu_2021_615930 crossref_primary_10_1038_gt_2010_176 crossref_primary_10_1007_s40588_019_00132_5 crossref_primary_10_1038_s41568_018_0070_z crossref_primary_10_4155_tde_11_22 crossref_primary_10_3390_cancers14174224 crossref_primary_10_3390_vaccines3040940 |
ContentType | Journal Article |
Copyright | Copyright © 2008 Landes Bioscience 2008 |
Copyright_xml | – notice: Copyright © 2008 Landes Bioscience 2008 |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 |
DOI | 10.4161/cbt.7.1.5195 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef MEDLINE - Academic |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef MEDLINE - Academic |
DatabaseTitleList | MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Biology |
EISSN | 1555-8576 |
EndPage | 151 |
ExternalDocumentID | 10_4161_cbt_7_1_5195 18059172 10905195 |
Genre | Research Paper Journal Article |
GroupedDBID | --- 00X 0VX 0YH 29B 30N 53G 5GY 6J9 AAAVI ABCCY ABEIZ ABFIM ACENM ACGFO ACGFS ACTIO ADBBV ADCVX AECIN AEGYZ AEISY AENEX AEXWM AFPKN AGYJP AIJEM AIRBT ALMA_UNASSIGNED_HOLDINGS ALQZU AOIJS AQRUH AVBZW BABNJ BAWUL BLEHA C1A CCCUG DGEBU DIK DKSSO E3Z EBS F5P HYE IH2 KSSTO KYCEM M4Z O9- OK1 P2P P6G RPM SJN TDBHL TFL TFT TFW TR2 TTHFI - 0R ABJVF AGCAB AIRXU AWQZV H13 RNANH ROSJB RTWRZ TQWBC 4.4 ACKZS ADFZZ AURDB BFWEY CGR CUY CVF CWRZV ECM EIF EJD EMOBN GROUPED_DOAJ IPNFZ LJTGL NPM PCLFJ RIG UDS AAYXX CITATION 7X8 |
ID | FETCH-LOGICAL-c448t-f89093578a55a32881cca563bf9b5146a20706ec7a02905ebbc2a2a5732c84923 |
ISSN | 1538-4047 |
IngestDate | Fri Oct 25 05:44:02 EDT 2024 Fri Aug 23 03:08:01 EDT 2024 Sat Sep 28 08:34:00 EDT 2024 Fri Jan 15 03:37:28 EST 2021 Sun Aug 04 07:04:42 EDT 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c448t-f89093578a55a32881cca563bf9b5146a20706ec7a02905ebbc2a2a5732c84923 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
PMID | 18059172 |
PQID | 69142737 |
PQPubID | 23479 |
PageCount | 7 |
ParticipantIDs | crossref_primary_10_4161_cbt_7_1_5195 proquest_miscellaneous_69142737 landesbioscience_primary_cbt_article_5195 informaworld_taylorfrancis_310_4161_cbt_7_1_5195 pubmed_primary_18059172 |
PublicationCentury | 2000 |
PublicationDate | 1/1/2008 2008/01/01 2008-Jan 2008-01-00 20080101 |
PublicationDateYYYYMMDD | 2008-01-01 |
PublicationDate_xml | – month: 01 year: 2008 text: 1/1/2008 day: 01 |
PublicationDecade | 2000 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | Cancer biology & therapy |
PublicationTitleAlternate | Cancer Biol Ther |
PublicationYear | 2008 |
Publisher | Taylor & Francis |
Publisher_xml | – name: Taylor & Francis |
References | 18347415 - Cancer Biol Ther. 2008 Jan;7(1):151-2 |
References_xml | |
SSID | ssj0027269 |
Score | 2.1489034 |
Snippet | RNAi has been successfully applied in genomic research, and it also holds considerable promise as a therapeutic approach to suppress disease-causing gene... |
SourceID | proquest crossref pubmed landesbioscience informaworld |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 145 |
SubjectTerms | Administration, Oral Animals Binding Biology Bioscience Calcium Cancer Cell Cycle Down-Regulation Gene Transfer Techniques Genes, bcl-2 Genetic Vectors Landes Mice Neoplasms - therapy Organogenesis Polymerase Chain Reaction Proteins RNA Interference RNA, Small Interfering - genetics Salmonella typhimurium - genetics |
Title | Oral administration of attenuated S. typhimurium carrying shRNA-expressing vectors as a cancer therapeutic |
URI | https://www.tandfonline.com/doi/abs/10.4161/cbt.7.1.5195 http://www.landesbioscience.com/journals/cbt/article/5195/ https://www.ncbi.nlm.nih.gov/pubmed/18059172 https://search.proquest.com/docview/69142737 |
Volume | 7 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3Nb9MwFLdgSAgOjG_KBvgABw7J4iSOk-M0DU0IisQ2qXCx7NRZh9R2ahME_PW8ZztLUjYJkKqosp26yu_nl_fs90HI6yIyTBllApZFVZBqkQbKJEXAp5mKTV6WqbZevuPs6DR9P-GTzlfVRpfUOix_XRlX8j-oQhvgilGy_4Ds5Y9CA3wHfOEKCMP1rzD-hNH1apD-1p7r16AIN8rqkiFuss7O583qvJljHuqVjWtazz6P9wPzw7nBQsN34-ruqDWGSyIVrPdhG5vV12EPXG-bvgm5Uw9zE3zxm9DjjnpfZw22TICNZz_b16V1K3By7wNWge7cg6yPwTH0nc0aNdiZyHs7E8ZLU86DnLsCL624FX-wyolO5tJKbop0NMAAh1LXoQhZiMlw-sMAkIu5hZfloCkyVwdoI4V223WT3IpBHqEgTKJxZ5fHWeFiInCyvf5UmFPW3zxQXAZpbe-SbfRCxQM9n4DUXG-vWL3l5D655w0Ouu_Y84DcMIuH5PZH71LxiHxDEtEhieiyoh2J6HFIeySiLYnoJomoJxFV8KGORLRHosfk9N3hycFR4AtwBCVY7XVQ5QWek4tcca6SOM8ZrHeeJboqNCjasJrhhZGZUqgoLiJutC5jFSsukrjMMfPfE7K1WC7MM0KZqHiaTJUpoyQFHTUvp1woFVdaC5AibETetE9XXrg8KxLsUwREAiBSSCYRkBGJ-o9e1nZfq3JFaGRy9S1vN-G5nALH-eXrx75qcZMgZ_HwTC3MslnLrGApqPpiRJ46OLu_6Qny_NqeHXKnWx-7ZKteNeYF6LK1fmmZ-Bsf0KT1 |
link.rule.ids | 315,783,787,27936,27937,60214,61003 |
linkProvider | Taylor & Francis |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Nb9QwEB1Bkfg4tAUKbCmtD3DgkDRO4jg5VlWrhbZbCVqp4mLZXkdtUbNVNkHAr-9MnKW7BQ4g5ZTYiu2Zsd94xs8Ab4vIce20C3gWlUFqZBpolxSBGGc6drm1qemyfEfZ8DT9eCbO5q76orRK8qFLTxTRzdVk3LQZTRZOeHzbmiaUIQ-JGeU-PMiI94tOb0SjW18r7m6z6-w5jVLpc95_q72wGi1wlT6BFUotpChNzyrp_g5Cu8VofwW-zLrhc1C-hm1jQvvzDsPjf_VzFZZ7iMp2vE49hXuuegYPj_og_HO4PK7xs15g3WWTkhFTZ9Uidh2zzyFrflyfX1y19UV7xayuazpOxabnn0Y7gfvus2_xxbcuaDBlGh8sht2v2dyRsDU43d872R0G_ZUNgUU_rwnKvKDIqsy1EDqJ85yjhogsMWVhEJqh_HGKyZyVOoqLSDhjbKxjLWQS25y44l7AUjWp3CtgXJYiTcba2ShBJ5Tndiyk1nFpjES94wN4NxOduvbMHAo9Gho4hQOnpOKKBm4A0bxcVdPthJT-2hKV_LnK-7uy__ULKtcbdV92a6YUCi2Twi26cpN2qrKCpwgO5QBeel25bWaOoBaR4_q_N20LHg1Pjg7V4YfRwWt47LNXaENoA5aaunVvECI1ZrMzhhvothEP |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB6VIlVwoLxZXvUBDhyS2kkcO8cKWJXXgoBK5WTZjq0W1OwqmyDg1zOOs7Rb4ABSTomt2J4Z-xvP-DPAo4o6pp12CSupTwojikS7vEp4XerMSWsLM2T5zsr9g-LlIT_cALk6CxPSKoMP7SNRxDBXB-Ne1D4YeIDju9Z0qUhZGohRLsBFBAA0aHhOZ6euVjZcZjeYc0ELEVPef6u9thitUZVehu2QWRiCNCOppPs7Bh3Wouk2fFr1IqagfEn7zqT2xzmCx__p5lW4MgJUshc16hpsuOY6bL0ZQ_A34PPbFj_rNc5dMvck8HQ2PSLXmnxISfd9cXR80rfH_Qmxum3DYSqyPHo_20vct5h7iy--DiGDJdH4YDHsfUvOHAi7CQfT5x-f7ifjhQ2JRS-vS7ysQlxVSM25zjMpGeoHL3PjK4PADKWPE0zprNA0qyh3xthMZ5qLPLMyMMXdgs1m3rg7QJjwvMhr7SzN0QVl0tZcaJ15YwRqHZvA45Xk1CLycij0Z8LAKRw4JRRTYeAmQM-KVXXDPoiPl5ao_M9VnpwX_a9fhHKjSY9ld1Y6odAuQ7BFN27eL1VZsQKhoZjA7agqp82UCGkRN97996btwNa7Z1P1-sXs1T24FFNXwm7Qfdjs2t49QHzUmYeDKfwEuDkPvA |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Oral+administration+of+attenuated+S.+typhimurium+carrying+shRNA-expressing+vectors+as+a+cancer+therapeutic&rft.jtitle=Cancer+biology+%26+therapy&rft.au=Yang%2C+Nan&rft.au=Zhu%2C+Xiangying&rft.au=Chen%2C+Lishan&rft.au=Li%2C+Shenghua&rft.date=2008-01-01&rft.eissn=1555-8576&rft.volume=7&rft.issue=1&rft.spage=145&rft_id=info:doi/10.4161%2Fcbt.7.1.5195&rft_id=info%3Apmid%2F18059172&rft.externalDocID=18059172 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1538-4047&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1538-4047&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1538-4047&client=summon |